July 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJuly 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
Market insights predict the global cell and gene therapy isolator industry will increase from USD 1.35 billion in 2024 to USD 4.47 billion by 2034, achieving a CAGR of 12.54%. The growing demand for cell and gene therapy products and technological advancements drive the market. North America dominated the global market due to the presence of key pl...
April 21, 2026
Market insights predict, the cell and gene overexpression service industry is expected to grow from USD 771.40 million in 2024 to USD 1,192.24 million by 2034, driven by a CAGR of 4.45%. The cell and gene overexpression service market is expanding due to growing demand for biologics as well as growth in plasmid-based transfection use. North America...
April 21, 2026
Projections indicate that, the global cell & gene therapy (CGT) biomanufacturing market will increase from USD 14.03 billion in 2024 to USD 41.41 billion by 2034, experiencing a CAGR of 11.43% over the next 10 years. Increasing outsourcing & contract manufacturing have driven the growth of the market. North America led the global market owi...
April 21, 2026
Market insights predict, the gene knockdown stable cell line service industry is expected to grow from USD 715 million in 2024 to USD 1557 million by 2034, driven by a CAGR of 8.16%. The market is growing due to the increasing use of stable cell models in drug development, target validation, and functional genomics studies. The strong biotech resea...
April 21, 2026
Based on market forecasts, the global cell and gene therapy tools and reagents market, projected at USD 10.04 billion in 2024, is expected to reach USD 27.3 billion by 2034, growing at a CAGR of 10.76% over the forecast period. The cell and gene therapy tools and reagents market is expanding due to growing CGT clinical trials as well as growing res...
April 21, 2026
According to market projections, the marine biotechnology sector is expected to grow from USD 6.72 billion in 2024 to USD 13.25 billion by 2034, reflecting a CAGR of 7.24%. A surge in technological advances and pharmaceutical applications is fueling the global market growth. North America’s ongoing wider demand for nutraceuticals and R&D ...
April 21, 2026
Market insights predict, the U.S. viral vector and plasmid DNA manufacturing industry is expected to grow from USD 2.85 billion in 2024 to USD 12.31 billion by 2034, driven by a CAGR of 15.72%. The boom in cell and gene therapies, advancements in personalized medicine, and high R&D investments support the expansion of industrial manufacturing i...
April 21, 2026
According to forecasts, the Middle East and Africa biotechnology market will grow from USD 46.53 billion in 2024 to USD 125.91 billion by 2034, with an expected CAGR of 10.80%. Rising food security concerns are estimated to drive the growth of the market. South Africa led the global market owing to its advanced research infrastructure in the region...
April 21, 2026
The globally rising chronic diseases and demand for efficient therapies are supporting the global market expansion. North America led the market due to the ongoing technological advances....
April 21, 2026
Projections indicate that, the APAC biotechnology market will increase from USD 372.23 billion in 2024 to USD 1611.67 billion by 2034, experiencing a CAGR of 14.80% over the next 10 years. The APAC biotechnology market is growing due to rising government initiatives in the region....
+1 804 441 9344
+65 3106 5601 or +91 87933 22019
